Zepbound vs Compounded Tirzepatide: What to Know

Same Active Ingredient, Different Products

Zepbound® and compounded tirzepatide both contain tirzepatide — the dual GIP/GLP-1 receptor agonist that has produced the highest average weight loss in clinical trials. But they are not the same product, and the differences matter when deciding how to access treatment.

Zepbound: The FDA-Approved Brand

Zepbound® is Eli Lilly's FDA-approved tirzepatide product for chronic weight management. Because it is FDA-approved, it has been evaluated for safety, efficacy, and manufacturing quality, and it is produced in standardized, pre-filled doses. The trade-off is cost: roughly $1,050-$1,400 per month without insurance, and coverage for weight loss is inconsistent.

Compounded Tirzepatide: The Accessible Alternative

Compounded tirzepatide is prepared by a state-licensed compounding pharmacy in response to a valid prescription. It is different from FDA-approved Zepbound® and Mounjaro® and has not been evaluated by the FDA for safety, efficacy, or quality. Formulation, strength, and inactive ingredients may differ. The advantage is access and cost — typically $200-$400 per month, with introductory offers as low as $149 for your first month at AvataCore.

Side-by-Side Comparison

Active Ingredient

Both: tirzepatide. The core mechanism — dual GIP/GLP-1 activation — is the same.

FDA Status

Zepbound: FDA-approved and evaluated for safety, efficacy, and quality.
Compounded: Not FDA-approved; not evaluated by the FDA.

Cost

Zepbound: ~$1,050-$1,400/month without insurance.
Compounded: typically $200-$400/month; far more accessible for cash-pay patients. See our tirzepatide cost guide.

Formulation

Zepbound: standardized pre-filled pens in fixed doses.
Compounded: may be offered in vials with flexible dosing; formulation and excipients can vary by pharmacy.

Access

Zepbound: requires a prescription and is filled at a retail or specialty pharmacy; subject to availability.
Compounded: available through licensed telehealth providers with provider oversight.

Which Is Right for You?

Zepbound may be the better fit if:

• Your insurance covers it with a manageable co-pay
• You prefer an FDA-approved product evaluated for quality and consistency
• You want standardized pre-filled pen dosing

Compounded tirzepatide may be the better fit if:

• You do not have insurance coverage for weight-loss medication
• Brand-name pricing is a barrier
• You want provider-guided telehealth access and are comfortable with a non-FDA-approved compounded preparation

How to Choose Safely

Whichever route you consider, treatment should be overseen by a licensed healthcare provider who reviews your health history, screens for contraindications, and monitors your progress. If you pursue compounded tirzepatide, choose a provider that partners with reputable, state-licensed compounding pharmacies that conduct independent potency and sterility testing. Learn what to look for in our compounded tirzepatide guide.